NCT03147911View on ClinicalTrials.gov

Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients

CompletedOBSERVATIONAL
Enrollment

1,181

Participants

Timeline

Start Date

April 6, 2017

Primary Completion Date

February 20, 2018

Study Completion Date

June 14, 2018

Conditions
Atrial Fibrillation
Trial Locations (9)

15355

Korea University Ansan Hospital, Ansan

15865

Wonkwang University Sanbon Hospital, Gyeonggi-do

21565

Gachon University Gil Medical Center, Incheon

35015

Chungnam National University Hospital, Daejeon

49241

Pusan National University Hospital, Busan

49267

Kosin University Gospel Hospital, Busan

02841

Jaemin Shim, Seoul

06973

Chung-ang University Hospital, Seoul

08308

Korea University Guro Hospital, Seoul

All Listed Sponsors
collaborator

Samjin Pharmaceutical Co., Ltd.

INDUSTRY

lead

Korea University Guro Hospital

OTHER

NCT03147911 - Clinical and Laboratory Predictors Associated With Stroke or Systemic Embolism in Low Risk Atrial Fibrillation Patients | Biotech Hunter | Biotech Hunter